This inventor holds 4 USPTO granted patents and 7 published patent applications. Top assignees: Kenjockety Biotechnology, Inc., Compugen Ltd. Corporation, William Robert Arathoon Living Trust Dated August 29, 2016. Active years: 2017-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 2 
1 out of 62 
1 out of 1 Years Active: 2017-2026
Title: Raffaella Briante: Innovator in Cancer Treatment
Introduction
Raffaella Briante is a notable inventor based in Burlingame, CA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of multi-specific antibodies. With a total of 4 patents, her work focuses on addressing critical challenges in oncology.
Latest Patents
Raffaella's latest patents include groundbreaking inventions such as "Efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related thereto." This patent provides multi-specific antibodies that target both a cellular efflux pump and a cancer-associated antigen. It also includes pharmaceutical compositions, nucleic acids, recombinant expression vectors, and kits that incorporate these antibodies. Additionally, she has developed methods for treating cancer by administering these multi-specific antibodies to patients. Another significant patent is related to "C1ORF32 antibodies, and uses thereof for treatment of cancer." This invention encompasses C1ORF32-specific antibodies, antibody fragments, alternative scaffolds, conjugates, and compositions aimed at cancer treatment.
Career Highlights
Throughout her career, Raffaella has worked with various organizations, including Compugen Ltd. and the William Robert Arathoon Living Trust Dated August 29, 2016. Her experience in these companies has contributed to her expertise in the field of biotechnology and cancer research.
Collaborations
Raffaella has collaborated with notable individuals in her field, including Gady S Cojocaru and Galit Rotman, who is a prominent woman in the industry. These collaborations have further enhanced her research and development efforts.
Conclusion
Raffaella Briante's innovative work in the development of multi-specific antibodies represents a significant advancement in cancer treatment. Her contributions continue to impact the field positively, showcasing her dedication to improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile